Link to this page
Physician Data Query
| Preferred Name | bethanechol chloride | |
| Synonyms |
2-[(aminocarbonyl)oxy]-N,N,N-trimethyl-1-propanaminium chloride |
|
| Definitions |
A synthetic quaternary ammonium base derivative, parasympathomimetic bethanechol is a slowly hydrolyzed muscarinic agonist with no nicotinic effects. Generally used to increase smooth muscle tone, bethanechol is used to treat reflux esophagitis and to initiate urination after surgery, in urinary infections, or for enlarged prostate. It may cause hypotension, cardiac rate changes, and bronchial spasms. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C28866" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C28866" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000786349 |
|
| altLabel |
2-[(aminocarbonyl)oxy]-N,N,N-trimethyl-1-propanaminium chloride
|
|
| CAS Registry |
590-63-6
|
|
| cui |
C0106169
|
|
| DATE FIRST PUBLISHED |
2017-01-17
|
|
| Date last modified |
2017-01-17
|
|
| definition |
A synthetic quaternary ammonium base derivative, parasympathomimetic bethanechol is a slowly hydrolyzed muscarinic agonist with no nicotinic effects. Generally used to increase smooth muscle tone, bethanechol is used to treat reflux esophagitis and to initiate urination after surgery, in urinary infections, or for enlarged prostate. It may cause hypotension, cardiac rate changes, and bronchial spasms. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C28866" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C28866" NCI Thesaurus)
|
|
| NCI ID |
C28866
|
|
| notation |
CDR0000786349
|
|
| ORIG STY |
Drug/agent
|
|
| prefLabel |
bethanechol chloride
|
|
| tui |
T109 T121
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |